Magri, V.; De Renzi, G.; Marino, L.; De Meo, M.; Siringo, M.; Gelibter, A.; Gareri, R.; Cataldi, C.; Giannini, G.; Santini, D.;
et al. Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors. Int. J. Mol. Sci. 2024, 25, 3752.
https://doi.org/10.3390/ijms25073752
AMA Style
Magri V, De Renzi G, Marino L, De Meo M, Siringo M, Gelibter A, Gareri R, Cataldi C, Giannini G, Santini D,
et al. Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors. International Journal of Molecular Sciences. 2024; 25(7):3752.
https://doi.org/10.3390/ijms25073752
Chicago/Turabian Style
Magri, Valentina, Gianluigi De Renzi, Luca Marino, Michela De Meo, Marco Siringo, Alain Gelibter, Roberta Gareri, Chiara Cataldi, Giuseppe Giannini, Daniele Santini,
and et al. 2024. "Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors" International Journal of Molecular Sciences 25, no. 7: 3752.
https://doi.org/10.3390/ijms25073752
APA Style
Magri, V., De Renzi, G., Marino, L., De Meo, M., Siringo, M., Gelibter, A., Gareri, R., Cataldi, C., Giannini, G., Santini, D., Nicolazzo, C., & Gazzaniga, P.
(2024). Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors. International Journal of Molecular Sciences, 25(7), 3752.
https://doi.org/10.3390/ijms25073752
